title: Commentary on Roberts et al. (2016): Bupropion and varenicline are efficacious and well-tolerated cessation medications for smokers with serious mental illness.
authors.affiliation: Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford, USA. jprochaska@stanford.edu.
authors.forename: Judith J
authors.initials: JJ
authors.lastname: Prochaska
mesh_terms: D001552:Benzazepines / Q000627:therapeutic use; D016642:Bupropion / Q000627:therapeutic use*; D006801:Humans; D009538:Nicotine / Q000627:therapeutic use; D018722:Nicotinic Agonists / Q000627:therapeutic use; D012907:Smoking / Q000188:drug therapy; D016540:Smoking Cessation; D014029:Tobacco Use Disorder / Q000188:drug therapy; D000068580:Varenicline
chemical_list: D001552:Benzazepines; D018722:Nicotinic Agonists; D016642:Bupropion; D009538:Nicotine; D000068580:Varenicline
keywords: Meta-analysis; psychiatry; serious mental illness; smoking; systematic review; tobacco